Blog
Something inspiring would go here to explain the blog.
-
This 37-year-old Toronto dad has aggressive cancer. The drug that could save him is approved — but he can’t access it
By
Why This Matters: Canadians already face long wait times for access to new medicines and only a small share of drugs launched globally are covered by Canadian public plans. As
-
Trump’s drug price push exposes Canada’s pricing flaws: John Adams and Nigel Rawson for Inside Policy
By
Why This Matters: Canada’s current approach to valuing innovative medicines is overly focused on low prices while missing the full value they bring to patients, caregivers, the health system, and
-
Innovative medicines as drivers of economic security – A strategic imperative for G7 economies
By
Why This Matters: Innovative medicines are engines of economic growth and security but without sustained focus and commitment to the sector, we risk losing future scientific progress. David Reddy, Director General
-
The Case for Fixing Canada’s Innovation Gap
By
Why This Matters: Without action, Canada becomes a less attractive market, access to new treatments is even further delayed, and our health, economic, and national security are weakened. Summary: Global
-
‘Prepare for the storm’: Canadians demand healthcare fixes in recent Nanos survey
By
Why This Matters: Public consensus is overwhelmingly in favour of changing our healthcare system. Summary: A new national public opinion survey shows the majority of Canadians are dissatisfied with the
-
Canada’s Wait for New Medicines Is Long – and About to Get Longer
By
Why This Matters: Canada already makes patients wait too long for new medicines. Global drug policy changes could make things worse. Canadians already have the longest wait in the G7
-
Enabling Innovation: The R&D Ecosystem for Medicines and Vaccines
By
Why This Matters: A strong research and development ecosystem is essential to driving medical innovation, supporting economic growth, and ensuring Canadians can benefit from the next generation of medicines. Investment
-
Canada’s Innovation Gap: Why Your Access to Medicines is at Risk
By
Why This Matters: Canada is falling behind in providing timely access to life-saving medications, but there is a critical opportunity to build a more resilient and competitive healthcare system. Dr.
-
Nine in Ten Canadians Call for Widespread Health System Change in New Nanos Research Survey
By
Why This Matters: National polling shows thatCanadians are ready to embrace healthcare reform, calling on decision-makers for practical policy changes so proven innovations can reach Canadians faster and more equitably. A
-
Trump wants higher drug prices in Canada. That might not be bad
By
Why This Matters: Drug pricing policies can shape how quickly Canadians gain access to new medicines and future innovation. In this opinion piece from the Financial Post, Nigel Rawson and